Biochemical and molecular characterization of diseases linked to motor proteins

Trends in Biochemical Sciences

Volumn 28, Issue 10, 2003, Pages 558-565

  Hirokawa, Nobutaka ^a   Takemura, Reiko ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; KINESIN; MUSCLE PROTEIN; MYOSIN;

ALZHEIMER DISEASE; CELL DIVISION; CELL TRANSPORT; CILIARY DYSKINESIA; CLINICAL FEATURE; DISEASE ASSOCIATION; GENE MUTATION; HEARING IMPAIRMENT; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMOTILE CILIA SYNDROME; MAY HEGGLIN ANOMALY; MICROTUBULE ORGANIZING CENTER; MISSENSE MUTATION; MULTIGENE FAMILY; MUSCLE WEAKNESS; NERVE FIBER TRANSPORT; NEUROPATHY; NONHUMAN; PATHOGENESIS; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; USHER SYNDROME; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DISEASE MODEL; EUKARYOTIC FLAGELLUM; GENETICS; METABOLISM; MICROTUBULE; MOUSE; MOUSE MUTANT; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CHARCOT-MARIE-TOOTH DISEASE; CILIA; DISEASE MODELS, ANIMAL; DYNEIN ATPASE; HUMANS; KINESIN; MICE; MICE, KNOCKOUT; MICROTUBULES; MODELS, BIOLOGICAL; MYOSINS;

EID: 0642377462     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2003.08.006     Document Type: Review

References (64)

1. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science. 279:1998;519-526.
2. Hirokawa N., Takemura R. Schliwa M. Kinesin superfamily proteins. Molecular Motors. 2003;79-109 Wiley-VCH.
3. Miki H., et al. All kinesin superfamily protein, KIF, genes in mouse and human. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7004-7011.
4. Rosenbaum J.L., Witman G.B. Intraflagellar transport. Nat. Rev. Mol. Cell Biol. 3:2002;813-825.
5. Zhao C., et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ Cell. 105:2001;587-597.
6. Kamal A., et al. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron. 28:2000;449-459.
7. Kamal A., et al. Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP. Nature. 414:2001;643-648.
8. Reid E., et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. 71:2002;1189-1194.
9. Hirokawa N. Stirring up development with the heterotrimeric kinesin KIF3. Traffic. 1:2000;29-34.
10. Igarashi P., Somlo S. Genetics and pathogenesis of polycystic kidney disease. J. Am. Soc. Nephrol. 13:2002;2384-2398.
11. Moyer J.H., et al. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science. 264:1994;1329-1333.
12. Taulman P.D., et al. Polaris, a protein involved in left-right axis patterning, localizes to basal bodies and cilia. Mol. Biol. Cell. 12:2001;589-599.
13. Yoder B.K., et al. Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium. Am. J. Physiol. Renal Physiol. 282:2002;F541-F552.
14. Pazour G.J., et al. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J. Cell Biol. 151:2000;709-718.
15. Nonaka S., et al. Randomization of left-right asymmetry due to loss of nodal cilia generating leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell. 95:1998;829-837.
16. -/- mice analysis. J. Cell Biol. 145:1999;825-836.
17. Marszalek J.R., et al. Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors. Cell. 102:2000;175-187.
18. Milisav I. Dynein and dynein-related genes. Cell Motil. Cytoskeleton. 39:1998;261-272.
19. Alberts B., et al. Molecular Biology of the Cell. 4th edn:2002;Garland Science.
20. Afzelius B.A., et al. Immotile cilia syndrome (primary ciliary dyskinesia), including Kartagener syndrome. Scriver C.R., et al. Metabolic and Molecular Bases of Inherited Diseases. 2000;4817-4827 McGrawHill.
21. Pennarun G., et al. Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Am. J. Hum. Genet. 65:1999;1508-1519.
22. Guichard C., et al. Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome). Am. J. Hum. Genet. 68:2001;1030-1035.
23. Bartoloni L., et al. Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10282-10286.
24. Ibanez-Tallon I., et al. Loss of function of axonemal dynein Mdnah5 causes primary ciliary dyskinesia and hydrocephalus. Hum. Mol. Genet. 11:2002;715-721.
25. Olbrich H., et al. Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry. Nat. Genet. 30:2002;143-144.
26. Zhang Y.J., et al. Identification of dynein heavy chain 7 as an inner arm component of human cilia that is synthesized but not assembled in a case of primary ciliary dyskinesia. J. Biol. Chem. 277:2002;17906-17915.
27. Vallee R.B., et al. LIS1: cellular function of a disease-causing gene. Trends Cell Biol. 11:2001;155-160.
28. Wynshaw-Boris A., Gambello M.J. LIS1 and dynein motor function in neuronal migration and development. Genes Dev. 15:2001;639-651.
29. Reiner O., et al. Isolation of a MillerDieker lissencephaly gene containing G protein β-subunit-like repeats. Nature. 364:1993;717-721.
30. Cardoso C., et al. Clinical and molecular basis of classical lissencephaly: Mutations in the LIS1 gene (PAFAH1B1). Hum. Mutat. 19:2002;4-15.
31. Smith D.S., et al. Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nat. Cell Biol. 2:2000;767-775.
32. Tai C.Y., et al. Role of dynein, dynactin, and CLIP-170 interactions in LIS1 kinetochore function. J. Cell Biol. 156:2002;959-968.
33. Berg J.S., et al. A millennial myosin census. Mol. Biol. Cell. 12:2001;780-794.
34. Seidman C.E., Seidman J.G. Hypertrophic cardiomyopathy. Scriver C.R., et al. Metabolic and Molecular Bases of Inherited Diseases. 2000;5433-5452 McGraw-Hill.
35. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 104:2001;557-567.
36. Frey N., et al. Decoding calcium signals involved in cardiac growth and function. Nat. Med. 6:2000;1221-1227.
37. Kelley M.J., et al. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat. Genet. 26:2000;106-108.
38. Seri M., et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner syndrome consortium. Nat. Genet. 26:2000;103-105.
39. Petit C. Usher syndrome: from genetics to pathogenesis. Annu. Rev. Genomics Hum. Genet. 2:2001;271-297.
40. Petit C., et al. Molecular genetics of hearing loss. Annu. Rev. Genet. 35:2001;589-646.
41. Gibson F., et al. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature. 374:1995;62-64.
42. Weil D., et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature. 374:1995;60-61.
43. Tamagawa Y., et al. A gene for a dominant form of non-syndromic sensorineural deafness (DFNA11) maps within the region containing the DFNB2 recessive deafness gene. Hum. Mol. Genet. 5:1996;849-852.
44. Weil D., et al. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat. Genet. 16:1997;191-193.
45. Maniak M. Cell adhesion: ushering in a new understanding of myosin VII. Curr. Biol. 11:2001;R315-R317.
46. Hasson T., et al. Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9815-9819.
47. Liu X., et al. Myosin VIIa participates in opsin transport through the photoreceptor cilium. J. Neurosci. 19:1999;6267-6274.
48. Probst F.J., et al. Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene. Science. 280:1998;1444-1447.
49. Wang A., et al. Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science. 280:1998;1447-1451.
50. Beyer L.A., et al. Hair cells in the inner ear of the pirouette and shaker 2 mutant mice. J. Neurocytol. 29:2000;227-240.
51. Avraham K.B., et al. The mouse Snell's waltzer deafness gene encodes an unconventional myosin required for structural integrity of inner ear hair cells. Nat. Genet. 11:1995;369-375.
52. Melchionda S., et al. MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am. J. Hum. Genet. 69:2001;635-640.
53. Walsh T., et al. From flies' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc. Natl. Acad. Sci. U. S. A. 99:2002;7518-7523.
54. Marks M.S., Seabra M.C. The melanosome: membrane dynamics in black and white. Nat. Rev. Mol. Cell Biol. 2:2001;738-748.
55. Seabra M.C., et al. Rab GTPases, intracellular traffic and disease. Trends Mol. Med. 8:2002;23-30.
56. Menasche G., et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat. Genet. 25:2000;173-176.
57. Wilson S.M., et al. A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc. Natl. Acad. Sci. U. S. A. 97:2000;7933-7938.
58. Bahadoran P., et al. Rab27a: a key to melanosome transport in human melanocytes. J. Cell Biol. 152:2001;843-850.
59. Wu X., et al. Rab27a is an essential component of melanosome receptor for Myosin Va. Mol. Biol. Cell. 13:2002;1735-1749.
60. Mercer J.A., et al. Novel myosin heavy chain encoded by murine dilute coat colour locus. Nature. 349:1991;709-713.
61. Pastural E., et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat. Genet. 16:1997;289-292.
62. Provance D.W., et al. Melanophilin, the product of the leaden locus, is required for targeting of myosin-Va to melanosomes. Traffic. 3:2002;124-132.
63. Haddad E.K., et al. Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice. J. Cell Biol. 152:2001;835-842.
64. Stinchcombe J.C., et al. Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J. Cell Biol. 152:2001;825-834.